A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for ...

Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

The researchers concluded that slower turnaround time for biomarker testing is associated with early non-targeted treatment in patients with ALK +/ EGFR + advanced NSCLC, a practice that is “common,” ...

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...

Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Cancer Stem Cell Market Cancer stem cells (CSCs) are a distinct subset of tumor cells with stem-like properties, including self-renewal and ...

Discover the growth rates of 5 different skin cancers, from slow-developing basal cell carcinomas to aggressive melanomas, ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...